By Devika Patel
Knoxville, Tenn., Nov. 10 - Alseres Pharmaceuticals, Inc. settled a private placement of stock for $1 million on Nov. 4, according to an 8-K filed Tuesday with the Securities and Exchange Commission.
The company sold 2.5 million common shares to Robert Gipson.
Based in Hopkinton, Mass., Alseres is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system.
| Issuer: | Alseres Pharmaceuticals, Inc.
|
| Issue: | Common stock
|
| Amount: | $1 million
|
| Shares: | 2.5 million
|
| Warrants: | No
|
| Investor: | Robert Gipson
|
| Settlement date: | Nov. 4
|
| Stock symbol: | Nasdaq: ALSE
|
| Stock price: | $0.37 at close Nov. 4
|
| Market capitalization: | $13.8 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
